| Sachin Sudmir Vaikunth, MD | |
|
6633 Forest Ave Ste 205, New Port Richey, FL 34653-2612 | |
| (727) 375-2849 | |
| (727) 266-4915 |
| Full Name | Sachin Sudmir Vaikunth |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 23 Years |
| Location | 6633 Forest Ave Ste 205, New Port Richey, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023217825 | NPI | - | NPPES |
| 1526000 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD47892 (Tennessee) | Secondary |
| 208600000X | Surgery | ME118760 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morton Plant North Bay Hospital | New port richey, FL | Hospital |
| Morton Plant Hospital | Clearwater, FL | Hospital |
| St Josephs Hospital | Tampa, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baycare Medical Group, Inc. | 6406753623 | 959 |
News Archive
Charles L. Sawyers, Chair of Memorial Sloan-Kettering's Human Oncology and Pathogenesis Program (HOPP), was awarded the Breakthrough Prize in Life Sciences today. The award - established by Art Levinson, Sergey Brin, Anne Wojcicki, Mark Zuckerberg, Priscilla Chan, and Yuri Milner - recognizes "excellence in research aimed at curing intractable diseases and extending human life."
The U.S. Food and Drug Administration (FDA) has announced its intentions of investigating whether inhalable caffeine sold in lipstick-sized canisters called AeroShot is safe for consumers and if its manufacturer was right to brand it as a dietary supplement.
As stem cell-based therapies are moving rapidly towards clinical trials, treatments for Parkinson's Disease (PD), an incurable condition, may be on the horizon. A recent announcement of a Phase I/IIa clinical trial involving transplantation of stem cells into the first human subjects has raised hope among patients and sparked discussions in the research community.
HHS Secretary Mike Leavitt on Thursday announced plans to implement a regulation intended to protect health care providers and other workers from disciplinary measures if they refuse to provide abortions or refer patients to other providers for abortions because of personal, religious or moral reasons, the Washington Post reports.
InVivo Therapeutics, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, today announced that the Company has entered into a sponsorship agreement with Boston-based Piers Park Sailing Center to support a non-profit sailing initiative for the disabled.
› Verified 3 days ago
| Entity Name | Baycare Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043269871 PECOS PAC ID: 6406753623 Enrollment ID: O20031216000718 |
News Archive
Charles L. Sawyers, Chair of Memorial Sloan-Kettering's Human Oncology and Pathogenesis Program (HOPP), was awarded the Breakthrough Prize in Life Sciences today. The award - established by Art Levinson, Sergey Brin, Anne Wojcicki, Mark Zuckerberg, Priscilla Chan, and Yuri Milner - recognizes "excellence in research aimed at curing intractable diseases and extending human life."
The U.S. Food and Drug Administration (FDA) has announced its intentions of investigating whether inhalable caffeine sold in lipstick-sized canisters called AeroShot is safe for consumers and if its manufacturer was right to brand it as a dietary supplement.
As stem cell-based therapies are moving rapidly towards clinical trials, treatments for Parkinson's Disease (PD), an incurable condition, may be on the horizon. A recent announcement of a Phase I/IIa clinical trial involving transplantation of stem cells into the first human subjects has raised hope among patients and sparked discussions in the research community.
HHS Secretary Mike Leavitt on Thursday announced plans to implement a regulation intended to protect health care providers and other workers from disciplinary measures if they refuse to provide abortions or refer patients to other providers for abortions because of personal, religious or moral reasons, the Washington Post reports.
InVivo Therapeutics, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, today announced that the Company has entered into a sponsorship agreement with Boston-based Piers Park Sailing Center to support a non-profit sailing initiative for the disabled.
› Verified 3 days ago
| Entity Name | Florida Hospital Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174955256 PECOS PAC ID: 2365679057 Enrollment ID: O20131231000600 |
News Archive
Charles L. Sawyers, Chair of Memorial Sloan-Kettering's Human Oncology and Pathogenesis Program (HOPP), was awarded the Breakthrough Prize in Life Sciences today. The award - established by Art Levinson, Sergey Brin, Anne Wojcicki, Mark Zuckerberg, Priscilla Chan, and Yuri Milner - recognizes "excellence in research aimed at curing intractable diseases and extending human life."
The U.S. Food and Drug Administration (FDA) has announced its intentions of investigating whether inhalable caffeine sold in lipstick-sized canisters called AeroShot is safe for consumers and if its manufacturer was right to brand it as a dietary supplement.
As stem cell-based therapies are moving rapidly towards clinical trials, treatments for Parkinson's Disease (PD), an incurable condition, may be on the horizon. A recent announcement of a Phase I/IIa clinical trial involving transplantation of stem cells into the first human subjects has raised hope among patients and sparked discussions in the research community.
HHS Secretary Mike Leavitt on Thursday announced plans to implement a regulation intended to protect health care providers and other workers from disciplinary measures if they refuse to provide abortions or refer patients to other providers for abortions because of personal, religious or moral reasons, the Washington Post reports.
InVivo Therapeutics, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, today announced that the Company has entered into a sponsorship agreement with Boston-based Piers Park Sailing Center to support a non-profit sailing initiative for the disabled.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sachin Sudmir Vaikunth, MD 6633 Forest Ave Ste 205, New Port Richey, FL 34653-2612 Ph: (727) 375-2849 | Sachin Sudmir Vaikunth, MD 6633 Forest Ave Ste 205, New Port Richey, FL 34653-2612 Ph: (727) 375-2849 |
News Archive
Charles L. Sawyers, Chair of Memorial Sloan-Kettering's Human Oncology and Pathogenesis Program (HOPP), was awarded the Breakthrough Prize in Life Sciences today. The award - established by Art Levinson, Sergey Brin, Anne Wojcicki, Mark Zuckerberg, Priscilla Chan, and Yuri Milner - recognizes "excellence in research aimed at curing intractable diseases and extending human life."
The U.S. Food and Drug Administration (FDA) has announced its intentions of investigating whether inhalable caffeine sold in lipstick-sized canisters called AeroShot is safe for consumers and if its manufacturer was right to brand it as a dietary supplement.
As stem cell-based therapies are moving rapidly towards clinical trials, treatments for Parkinson's Disease (PD), an incurable condition, may be on the horizon. A recent announcement of a Phase I/IIa clinical trial involving transplantation of stem cells into the first human subjects has raised hope among patients and sparked discussions in the research community.
HHS Secretary Mike Leavitt on Thursday announced plans to implement a regulation intended to protect health care providers and other workers from disciplinary measures if they refuse to provide abortions or refer patients to other providers for abortions because of personal, religious or moral reasons, the Washington Post reports.
InVivo Therapeutics, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries, today announced that the Company has entered into a sponsorship agreement with Boston-based Piers Park Sailing Center to support a non-profit sailing initiative for the disabled.
› Verified 3 days ago
Dr. Eric C. Borock, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 6633 Forest Ave, Suite 205, New Port Richey, FL 34653 Phone: 727-375-2849 Fax: 727-266-4915 | |
Dr. Louis I Astra, MD Surgery Medicare: Medicare Enrolled Practice Location: 8607 Easthaven Ct, Suite 102, New Port Richey, FL 34655 Phone: 727-375-2849 Fax: 727-372-3402 | |
Dr. James K. Condon, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 6804 Cecelia Dr, New Port Richey, FL 34653 Phone: 727-232-0644 Fax: 888-546-0488 | |
Nicole Alison Allred Figel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4619 Little Rd, New Port Richey, FL 34655 Phone: 813-961-1331 Fax: 813-961-6336 | |
Dr. Neria H Hebbar, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 5347 Main Street, Suite 303, New Port Richey, FL 34652 Phone: 727-845-1662 Fax: 727-841-7579 | |
Tiffani D Shelton, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 7657 Cita Ln, New Port Richey, FL 34653 Phone: 813-563-2310 Fax: 941-208-6002 |